What’s Propelling FISHER &amp PAYKEL HEALTHCARE CORPORATI (OTCMKTS:FSPKF) After Higher Shorts Reported?

Fisher & Paykel Healthcare Corporation Limited (OTCMKTS:FSPKF) Logo

The stock of FISHER &amp PAYKEL HEALTHCARE CORPORATI (OTCMKTS:FSPKF) registered an increase of 13.43% in short interest. FSPKF’s total short interest was 337,100 shares in December as published by FINRA. Its up 13.43% from 297,200 shares, reported previously. With 2,300 shares average volume, it will take short sellers 147 days to cover their FSPKF’s short positions.

It closed at $9.13 lastly. It is down 0.00% since December 8, 2017 and is . It has underperformed by 15.62% the S&P500.

Fisher & Paykel Healthcare Corporation Limited, together with its subsidiaries, designs, makes, and markets medical device products and systems for use in respiratory and acute care, and surgery; and for the treatment of obstructive sleep apnea . The company has market cap of $4.87 billion. It operates through four divisions: New Zealand, North America, Europe, and Asia-Pacific. It has a 37.25 P/E ratio. The firm offers flow generator and humidifiers, nasal cannulas, single-use and reusable chambers, breathing circuits, interfaces, surgical humidification systems, and accessories that are designed to humidify the gases that a patient receives during mechanical ventilation, non-invasive ventilation, nasal high flow therapy, laparoscopic, and open surgeries.

More recent Fisher & Paykel Healthcare Corporation Limited (OTCMKTS:FSPKF) news were published by: Seekingalpha.com which released: “Fisher & Paykel Healthcare (FSPKY) Investor Presentation – Slideshow – Seeking Alpha” on October 16, 2017. Also Investorplace.com published the news titled: “The 3 Best Ways to Buy International Stocks – Investorplace.com” on July 25, 2016. Seekingalpha.com‘s news article titled: “Fisher & Paykel Healthcare Corp. Ltd. 2018 Q2 – Results – Earnings Call Slides – Seeking Alpha” with publication date: November 21, 2017 was also an interesting one.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.